This is critically exemplified by the pathophysiology of SCN1A‐deficient epilepsies like Dravet syndrome, where the NaV1.1, preferentially enriched in GABAergic interneurons, is already compromised [49, 50]. The gene discussed is SCN1A; the disease is epilepsy.